Citations

Mayo Clinic

Showing 10 of 108522 citations.

The Affordable Care Act: a case study for understanding and applying complexity concepts to health care reform
Larkin, D. Justin , Swanson, Robert Chad , Fuller, Spencer , Cortese, Denis A.

Journal of Evaluation in Clinical Practice | November 4, 2014 | Volume: 22 | Issue: 1 | Pages: 133-140

10.1111/jep.12271 | PMID 25367816 Get It

AbstractRationale, aims and objectivesThe current health system in the United States is the result of a history of patchwork policy decisions and cultural assumptions that have led to persistent contradictions in practice, gaps in coverage, unsustainable costs, and inconsistent outcomes. In working toward a more efficient health system, understanding and applying complexity science concepts will allow for policy that better promotes desired outcomes and minimizes the effects of unintended consequences.MethodsThis paper will consider three applied complexity science concepts in the context of the Patient Protection and Affordable Care Act (PPACA): developing a shared vision around reimbursement for value, creating an environment for emergence through simple rules, and embracing transformational leadership at all levels.Results and conclusionsTransforming the US health system, or any other health system, will be neither easy nor quick. Applying complexity concepts to health reform efforts, however, will facilitate long‐term change in all levels, leading to health systems that are more effective, efficient, and equitable.
Faculty Opinions recommendation of PARP-2 and PARP-3 are selectively activated by 5' phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1.
Kaufmann, Scott H. , Meng, Wei , Kaufmann, Scott H

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 4, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718449416.793501137 Get It

Faculty Opinions recommendation of Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure.
Kaufmann, Scott H. , Dai, Haiming , Kaufmann, Scott H

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 4, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718437260.793501136 Get It

Classification of failure of limb salvage after reconstructive surgery for bone tumours
Ruggieri, Pietro , Windhager, Reinhard , Funovics, Philipp T. , Gibbons, C. L. M. H. , Hornicek, Francis J. , Temple, H. Thomas , Letson, G. Douglas , Henderson, Eric R. , O’Connor, Mary I. , Guo, Wei , Ruggieri, Pietro

The Bone & Joint Journal | November 4, 2014 | Volume: 96-B | Issue: 11 | Pages: 1436-1440

10.1302/0301-620x.96b11.34747 | PMID 25371453 Get It

Previous classification systems of failure of limb salvage focused primarily on endoprosthetic failures and lacked sufficient depth for the effective study of the causes of failure. In order to address these inadequacies, the International Society of Limb Salvage (ISOLS) formed a committee to recommend revisions of the previous systems. The purpose of this study was to report on their recommendations. The modifications were prepared using an earlier, evidence-based model with subclassification based on the existing medical literature. Subclassification for all five primary types of failure of limb salvage following endoprosthetic reconstruction were formulated and a complementary system was derived for the failure of biological reconstruction. An additional classification of failure in paediatric patients was also described. Limb salvage surgery presents a complex array of potential mechanisms of failure, and a complete and precise classification of types of failure is required. Earlier classification systems lacked specificity, and the evidence-based system outlined here is designed to correct these weaknesses and to provide a means of reporting failures of limb salvage in order to allow the interpretation of outcome following reconstructive surgery. Cite this article: Bone Joint J 2014;96-B:1436–40.
Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting Analysis Dates for the IDEA Collaboration
Renfro, Lindsay A. , Grothey, Axel, Floriani, Irene, Bonnetain, Franck, Niedzwiecki, Donna , Yamanaka, Takeharu , Souglakos, Ioannis , Yothers, Greg , Grothey, Axel M, Paul, James , Sargent, Daniel J. , Yothers, Greg , Niedzwiecki, Donna

Forum of Clinical Oncology | November 4, 2014 | Volume: 5 | Issue: 2 | Pages: 1-7

10.2478/fco-2014-0006 | PMID 26989447 Get It

Abstract Purpose: Clinical trials are expensive and lengthy, where success of a given trial depends on observing a prospectively defined number of patient events required to answer the clinical question. The point at which this analysis time occurs depends on both patient accrual and primary event rates, which typically vary throughout the trial's duration. We demonstrate real-time analysis date projections using data from a collection of six clinical trials that are part of the IDEA collaboration, an international preplanned pooling of data from six trials testing the duration of adjuvant chemotherapy in stage III colon cancer, and we additionally consider the hypothetical impact of one trial's early termination of follow-up. Patients and Methods: In the absence of outcome data from IDEA, monthly accrual rates for each of the six IDEA trials were used to project subsequent trial-specific accrual, while historical data from similar Adjuvant Colon Cancer Endpoints (ACCENT) Group trials were used to construct a parametric model for IDEA's primary endpoint, disease-free survival, under the same treatment regimen. With this information and using the planned total accrual from each IDEA trial protocol, individual patient accrual and event dates were simulated and the overall IDEA interim and final analysis times projected. Projections were then compared with actual (previously undisclosed) trial-specific event totals at a recent census time for validation. The change in projected final analysis date assuming early termination of follow-up for one IDEA trial was also calculated. Results: Trial-specific predicted event totals were close to the actual number of events per trial for the recent census date at which the number of events per trial was known, with the overall IDEA projected number of events only off by eight patients. Potential early termination of follow-up by one IDEA trial was estimated to postpone the overall IDEA final analysis date by 9 months. Conclusions: Real-time projection of the final analysis time during a trial, or the overall analysis time during a trial collaborative such as IDEA, has practical implications for trial feasibility when these projections are translated into additional time and resources required.
Circulating Aldosterone and Natriuretic Peptides in the General Community
Buglioni, Alessia , Cannone, Valentina , Cataliotti, Alessandro , Sangaralingham, S. Jeson , Heublein, Denise M., Bailey, Kent R. , Rodeheffer, Richard J. , Dessı̀-Fulgheri, Paolo, Sarzani, Riccardo , Burnett, John C. , Dessì-Fulgheri, Paolo, Sangaralingham, S. Jeson , Scott, Christopher G.

Hypertension | November 4, 2014 | Volume: 65 | Issue: 1 | Pages: 45-53

10.1161/hypertensionaha.114.03936 | PMID 25368032 Get It

We sought to investigate the role of aldosterone as a mediator of disease and its relationship with the counter-regulatory natriuretic peptide (NP) system. We measured plasma aldosterone (n=1674; aged≥45 years old) in a random sample of the general population from Olmsted County, MN. In a multivariate logistic regression model, aldosterone analyzed as a continuous variable was associated with hypertension (odds ratio [OR]=1.75; 95% confidence interval [CI]=1.57–1.96; P <0.0001), obesity (OR=1.34; 95% CI=1.21–1.48; P <0.0001), chronic kidney disease (OR=1.39; 95% CI=1.22–1.60; P <0.0001), central obesity (OR=1.47; 95% CI=1.32–1.63; P <0.0001), metabolic syndrome (OR=1.41; 95% CI=1.26–1.58; P <0.0001), high triglycerides (OR=1.23; 95% CI=1.11–1.36; P <0.0001), concentric left ventricular hypertrophy (OR=1.22; 95% CI=1.09–1.38; P =0.0007), and atrial fibrillation (OR=1.24; 95% CI=1.01–1.53; P =0.04), after adjusting for age and sex. The associations with hypertension, central obesity, metabolic syndrome, triglycerides, and concentric left ventricular hypertrophy remained significant after further adjustment for body mass index, NPs, and renal function. Furthermore, aldosterone in the highest tertile correlated with lower NP levels and increased mortality. Importantly, most of these associations remained significant even after excluding subjects with aldosterone levels above the normal range. In conclusion, we report that aldosterone is associated with hypertension, chronic kidney disease, obesity, metabolic syndrome, concentric left ventricular hypertrophy, and lower NPs in the general community. Our data suggest that aldosterone, even within the normal range, may be a biomarker of cardiorenal and metabolic disease. Further studies are warranted to evaluate a therapeutic and preventive strategy to delay the onset and progression of disease, using mineralocorticoid antagonists or chronic NP administration in high-risk subjects identified by plasma aldosterone.
Immature Recent Thymic Emigrants Are Eliminated by Complement
Hsu, Fan‐Chi , Shapiro, Michael J. , Chen, Meibo W., McWilliams, Douglas C., Seaburg, Lauren, Tangen, Sarah, Seaburg, Lauren M, Tangen, Sarah N, Shapiro, Virginia Smith

The Journal of Immunology | November 4, 2014 | Volume: 193 | Issue: 12 | Pages: 6005-6015

10.4049/jimmunol.1401871 | PMID 25367120 Get It

Abstract Recent thymic emigrants (RTEs) must undergo phenotypic and functional maturation to become long-lived mature naive T cells. In CD4-cre NKAP conditional knockout mice, NKAP-deficient RTEs fail to complete T cell maturation. In this study, we demonstrate that NKAP-deficient immature RTEs do not undergo apoptosis, but are eliminated by complement. C3, C4, and C1q are bound to NKAP-deficient peripheral T cells, demonstrating activation of the classical arm of the complement pathway. As thymocytes mature and exit to the periphery, they increase sialic acid incorporation into cell surface glycans. This is essential to peripheral lymphocyte survival, as stripping sialic acid with neuraminidase leads to the binding of natural IgM and complement fixation. NKAP-deficient T cells have a defect in sialylation on cell surface glycans, leading to IgM recruitment. We demonstrate that the defect in sialylation is due to aberrant α2,8-linked sialylation, and the expression of three genes (ST8sia1, ST8sia4, and ST8sia6) that mediate α2,8 sialylation are downregulated in NKAP-defcient RTEs. The maturation of peripheral NKAP-deficient T cells is partially rescued in a C3-deficient environment. Thus, sialylation during T cell maturation is critical to protect immature RTEs from complement in the periphery.
Getting Maintenance of Certification to Work
Cook, David A. , Holmboe, Eric S. , Sorensen, Kristi J., Wilkinson, John M. , Berger, Richard A. , Berger, Richard A.

JAMA Internal Medicine | November 3, 2014 | Volume: 175 | Issue: 1 | Pages: 35

10.1001/jamainternmed.2014.5437 | PMID 25365596 Get It

Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult
Raman, Mekala R., Wiste, Heather J. , Senjem, Matthew L. , Ward, Chadwick P., Kantarci, Kejal , Jack, Clifford R. , Senjem, Matthew L , Kantarci, Kejal

Neurology | November 3, 2014 | Volume: 83 | Issue: 19 | Pages: 1771-1772

10.1212/wnl.0000000000000957 | PMID 25367059 Get It